187 related articles for article (PubMed ID: 19583730)
21. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
22. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
23. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
[TBL] [Abstract][Full Text] [Related]
24. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
Lai MD; Lin WC; Sun YM; Chang FL
Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
[TBL] [Abstract][Full Text] [Related]
27. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells.
Rudolf E; Rudolf K; Cervinka M
Cell Biol Toxicol; 2008 Apr; 24(2):123-41. PubMed ID: 17610029
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
29. Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53.
Qiao L; McKinstry R; Gupta S; Gilfor D; Windle JJ; Hylemon PB; Grant S; Fisher PB; Dent P
Hepatology; 2002 Jul; 36(1):39-48. PubMed ID: 12085347
[TBL] [Abstract][Full Text] [Related]
30. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
31. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
Gan L; Wang J; Xu H; Yang X
Prostate; 2011 Aug; 71(11):1158-66. PubMed ID: 21656826
[TBL] [Abstract][Full Text] [Related]
32. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
33. Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy.
Suvasini R; Somasundaram K
Oncogene; 2010 Jun; 29(25):3605-18. PubMed ID: 20418912
[TBL] [Abstract][Full Text] [Related]
34. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo.
Tan W; Yu HG; Luo HS
Mol Med Rep; 2014 Dec; 10(6):3275-81. PubMed ID: 25270341
[TBL] [Abstract][Full Text] [Related]
36. Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.
Kim KK; Kawar NM; Singh RK; Lange TS; Brard L; Moore RG
Gynecol Oncol; 2011 Jul; 122(1):183-9. PubMed ID: 21529906
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
[TBL] [Abstract][Full Text] [Related]
38. Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer.
Lin KW; Huang AM; Lin CC; Chang CC; Hsu WC; Hour TC; Pu YS; Lin CN
Eur J Pharmacol; 2014 Oct; 740():742-51. PubMed ID: 24933647
[TBL] [Abstract][Full Text] [Related]
39. Induction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPK.
Feng R; Zhai WL; Yang HY; Jin H; Zhang QX
Biochem Biophys Res Commun; 2011 Mar; 406(2):299-304. PubMed ID: 21320468
[TBL] [Abstract][Full Text] [Related]
40. G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.
Zhang X; Liu D; Hayashida Y; Okazoe H; Hashimoto T; Ueda N; Sugimoto M; Kakehi Y
Int J Mol Sci; 2015 Oct; 16(10):24319-31. PubMed ID: 26473854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
